TRF - VCA - Adult/Pediatric |
Fields to be completed by members |
|
|
|
Form Section |
Field Label |
Notes |
Recipient Information |
Recipient First Name |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
Recipient Last Name |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
Recipient Middle Initial |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
DOB |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
SSN |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
Gender |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
HIC |
Display Only - Cascades from TRR |
Recipient Information |
Transplant Date |
Display Only - Cascades from Removal Worksheet |
Recipient Information |
State of Permanent Residence |
|
Recipient Information |
Permanent zip code |
|
Provider Information |
Treating Reconstructive Surgeon Name |
|
Provider Information |
Treating Reconstructive Surgeon NPI# |
|
Provider Information |
Treating Transplant Physician Name |
|
Provider Information |
Treating Transplant Physician NPI# |
|
Provider Information |
Follow-up Care Provided By: |
|
Donor Information |
UNOS Donor ID # |
Display Only - Cascades from Removal Worksheet |
Donor Information |
Donor Type |
Display Only - Cascades from Removal Worksheet |
Donor Information |
OPO |
Display Only - Cascades from Removal Worksheet |
Patient Status |
Date Last Seen, Retransplanted, or Death |
|
Patient Status |
Patient Status |
|
Patient Status |
Primary Cause of Death |
|
Patient Status |
Primary Cause of Death - Other Specify |
|
Patient Status |
Has patient been hospitalized since the Last Patient Status Date |
|
Patient Status |
Number of Hospitalizations |
|
Socio-Demographic Information |
Working for income |
|
Socio-Demographic Information |
Working for income - If Yes, indicate the recipient's working status |
|
Socio-Demographic Information |
Working for income - If No, Not Working Due To |
|
Socio-Demographic Information - Source of Payment |
Grant funding |
|
Socio-Demographic Information - Source of Payment |
Institutional funding |
|
Socio-Demographic Information - Source of Payment |
Primary Source of Payment |
|
Socio-Demographic Information - Source of Payment |
Primary Source of Payment - Foreign Government, Specify |
|
Socio-Demographic Information - Source of Payment |
Secondary Source of Payment |
|
Functional Status |
Cognitive Development |
|
Functional Status |
Motor Development |
|
Functional Status |
Psychosocial consult performed |
|
Functional Status - SF-36 score - Physical Health |
Physical Functioning (PF) score |
|
Functional Status - SF-36 score - Physical Health |
Role-Physical (RP) score |
|
Functional Status - SF-36 score - Physical Health |
Bodily Pain (BP) score |
|
Functional Status - SF-36 score - Physical Health |
General Health (GH) score |
|
Functional Status - SF-36 score - Mental Health |
Vitality (VT) score |
|
Functional Status - SF-36 score - Mental Health |
Social Functioning (SF) score |
|
Functional Status - SF-36 score - Mental Health |
Role-Emotional (RE) score |
|
Functional Status - SF-36 score - Mental Health |
Mental Heath (MH) score |
|
Functional Status - Upper Limb |
DASH Score |
|
Functional Status - Upper Limb |
Carroll Test Score - Left |
|
Functional Status - Upper Limb |
Carroll Test Score - Right |
|
Functional Status - Upper Limb |
Sensibility Test - Semmes Weinstein - Left |
|
Functional Status - Upper Limb |
Sensibility Test - Semmes Weinstein - Right |
|
Functional Status - Craniofacial |
Olfactory function restored |
|
Functional Status - Craniofacial - Sensory Testing |
2 point discrimination (mm) |
|
Functional Status - Craniofacial - Sensory Testing - Hot/cold testing |
Can feel heat |
|
Functional Status - Craniofacial - Sensory Testing - Hot/cold testing |
Can feel cold |
|
Functional Status - Craniofacial - Motor function |
Oral competence |
|
Functional Status - Craniofacial - Motor function |
Corneal protection |
|
Functional Status - Craniofacial |
Functional occlusion restored |
|
Functional Status - Craniofacial |
Decannulation (if the patient had a tracheostomy) |
|
Functional Status - Craniofacial |
Feeding Tube Removed (if the patient had a feeding tube to start with) |
|
Functional Status - Craniofacial - Speech Intelligibility Tests |
Speaking rate |
|
Functional Status - Craniofacial - Speech Intelligibility Tests |
Percent Intelligibility |
|
Clinical Information |
Height (inches) |
|
Clinical Information |
Weight (lbs.) |
|
Clinical Information |
BMI (Body Mass Index) |
Display Only - Calculated |
Clinical Information - Noncompliance |
Immunosuppression |
|
Clinical Information - Noncompliance |
Rehabilitation |
|
Clinical Information - Noncompliance |
Level of Activity |
|
Clinical Information - Noncompliance |
Other |
|
Clinical Information - Noncompliance |
Other - Other Specify |
|
Clinical Information |
Graft Status |
|
Clinical Information |
Date of Graft Failure |
|
Clinical Information - Causes of Graft Failure |
Acute Rejection |
|
Clinical Information - Causes of Graft Failure |
Acute Rejection - Banff score |
|
Clinical Information - Causes of Graft Failure |
Acute Rejection - Visual skin changes |
|
Clinical Information - Causes of Graft Failure |
Chronic Rejection |
|
Clinical Information - Causes of Graft Failure |
Chronic Rejection - Visual skin changes |
|
Clinical Information - Causes of Graft Failure |
Ischemia |
|
Clinical Information - Causes of Graft Failure |
Sepsis / Infection |
|
Clinical Information - Causes of Graft Failure |
Trauma |
|
Clinical Information - Causes of Graft Failure |
Patient requested removal |
|
Clinical Information - Causes of Graft Failure |
Non-compliance: immunosuppression |
|
Clinical Information - Causes of Graft Failure |
Non-compliance: rehabilitation |
|
Clinical Information - Causes of Graft Failure |
Non-compliance: level of activity |
|
Clinical Information - Causes of Graft Failure |
Other |
|
Clinical Information - Causes of Graft Failure |
Other - Other Specify |
|
Clinical Information - Most Recent Lab Data |
Serum Creatinine (mg/dL) |
|
Clinical Information - Most Recent Lab Data |
Hemoglobin A1c (%) |
|
Clinical Information - Most Recent Lab Data |
Donor Specific Antibodies (DSA) |
|
Clinical Information |
Did patient have any acute rejection episodes during the follow-up period |
|
Clinical Information |
Did patient have any acute rejection episodes during the follow-up period - Number of episodes |
|
Clinical Information |
{For each episode} Date of acute rejection diagnosis |
|
Clinical Information |
{For each episode} Acute rejection was treated |
|
Clinical Information |
{For each episode} Visual skin changes |
|
Clinical Information |
{For each episode} Biopsy was done to confirm acute rejection |
|
Clinical Information |
{For each episode} Banff Score |
|
Clinical Information - Complications |
New onset diabetes |
|
Clinical Information - Complications |
Metabolic Complications |
|
Clinical Information - Complications |
Infectious Complications |
|
Clinical Information - Complications |
Other Complications |
|
Clinical Information - Complications |
Other Complications - Other Specify |
|
Clinical Information |
Post Transplant Malignancy |
|
Clinical Information - Post-transplant Malignancy |
Donor Related |
|
Clinical Information - Post-transplant Malignancy - Donor Related |
Diagnosis date: |
|
Clinical Information - Post-transplant Malignancy - Donor Related |
Tumor type |
|
Clinical Information - Post-transplant Malignancy |
Recurrence of Pre-Tx Tumor |
|
Clinical Information - Post-transplant Malignancy - Recurrence of Pretransplant Malignancy |
Date of recurrence |
|
Clinical Information - Post-transplant Malignancy - Recurrence of Pretransplant Malignancy |
Type of pre-existing tumor |
|
Clinical Information - Post-transplant Malignancy - Recurrence of Pretransplant Malignancy |
Type of pre-existing tumor - Other, Specify |
|
Clinical Information - Post-transplant Malignancy |
De Novo Solid Tumor |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Diagnosis date |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: Skin: //squamous cell: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: Skin: //basal cell: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: Skin: //melanoma: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Kaposi's sarcoma: cutaneous: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Kaposi's sarcoma: visceral: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Brain: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: Brain: //Other specify: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Renal carcinoma - specify site(s): |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Carcinoma of vulva, perineum or penis, scrotum: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Carcinoma of the uterus: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Ovarian: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Testicular: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Esophagus: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Stomach: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Small intestine: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Pancreas: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Larynx: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Tongue, throat: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Thyroid: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Bladder: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Breast: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Prostate: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Colo-rectal: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Primary hepatic tumor: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Metastatic liver tumor: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Lung: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types://Leukemia: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Sarcomas: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Other cancers: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Other Cancers: //Site(s): |
|
Clinical Information - Post-transplant Malignancy - Post Transplant De Novo Solid Tumor |
Tumor Types: //Primary unknown: |
|
Clinical Information - Post-transplant Malignancy |
De Novo Lymphoproliferative disease and Lymphoma |
|
Clinical Information - Post-transplant Malignancy - Post Transplant Lymphoproliferative Disease and Lymphoma |
PTLD: //Diagnosis date: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant Lymphoproliferative Disease and Lymphoma |
PTLD: //Pathology: |
|
Clinical Information - Post-transplant Malignancy - Post Transplant Lymphoproliferative Disease and Lymphoma |
PTLD: Pathology: //Other Specify: |
|
Treatment |
Antiviral |
|
Treatment |
Antibiotic |
|
Treatment |
Antifungal |
|
Topical Immunosuppressive Medications |
Immunosuppression medications |
|
Topical Immunosuppressive Medications |
Immunosuppression medications - Other Specify |
|
Topical Immunosuppressive Medications |
Previous maintenance indication |
|
Topical Immunosuppressive Medications |
Current maintenance indication |
|
Topical Immunosuppressive Medications |
Anti-rejection indication |
|
Non-Topical Immunosuppressive Medications |
Immunosuppression medications |
|
Non-Topical Immunosuppressive Medications |
Immunosuppression medications - Other Specify |
|
Non-Topical Immunosuppressive Medications |
Previous maintenance indication |
|
Non-Topical Immunosuppressive Medications |
Current maintenance indication |
|
Non-Topical Immunosuppressive Medications |
Anti-rejection indication |
|
|
|
|
|
|
|
|
|
|
PUBLIC BURDEN STATEMENT: |
|
|
The private, non-profit Organ Procurement and Transplantation Network (OPTN) collects this information in order to perform the following OPTN functions: to assess whether applicants meet OPTN Bylaw requirements for membership in the OPTN; and to monitor compliance of member organizations with OPTN Obligations. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this information collection is 0915-0157 and it is valid until XX/XX/202X. This information collection is required to obtain or retain a benefit per 42 CFR §121.11(b)(2). All data collected will be subject to Privacy Act protection (Privacy Act System of Records #09-15-0055). Data collected by the private non-profit OPTN also are well protected by a number of the Contractor’s security features. The Contractor’s security system meets or exceeds the requirements as prescribed by OMB Circular A-130, Appendix III, Security of Federal Automated Information Systems, and the Departments Automated Information Systems Security Program Handbook. The public reporting burden for this collection of information is estimated to average 0.7 hours per response, including the time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 14N136B, Rockville, Maryland, 20857 or paperwork@hrsa.gov.
|